Clinical Trial

68Ga-FAPI PET/CT in Patients With Various Types of Cancer

Name: 68Ga-FAPI PET/CT in Patients With Various Types of Cancer — clinical trial record (NCT04499365)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

To evaluate the potential usefulness of 68Ga-DOTA/NOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer.

Protocol Amendment History 2 amendments

This ClinicalTrials.gov record has been amended 2 times since 2020-08-04; most recent amendment 2026-07-19.

Trial Details

NCT Number	NCT04499365
Lead Sponsor	First Affiliated Hospital of Fujian Medical University
Conditions	Tumor, Positron-Emission Tomography, Metastasis
Enrollment	500 participants
Start Date	2020-08-15
Primary Completion	2027-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-21